Blocknomi
TLDR AbbVie Phase 3 lymphoma trial cuts progression or death risk by 51% in DLBCL Epcoritamab plus R-CHOP delivers a major Phase 3 win in frontline lymphoma care AbbVie gains…
Related articles
-
Nick Valdez Reveals Key Entry Price for Cardano Longs
The Crypto Basic Published 16.10.2026 09:08
-
XRP spot ETF cumulative inflows surpass $1.8 billion: XRP holders can earn up to $9,000 per day
Crypto.News Published 19.10.2026 12:02
-
Shayne Coplan Renews Speculation About Polymarket Token
CryptoPotato Published 14.10.2026 20:41
-
Solana price falls 9% ahead of major October 21 upgrade
Crypto.News Published 14.10.2026 07:11
-
OKX Raises Strategic Funding at $25 Billion Valuation From Circle and Ripple
Blocknomi Published 07.10.2026 09:41
-
BingX, YouHodler added to ESMA MiCA register in latest update
Cointelegraph Published 19.10.2026 10:13
-
New York, Wyoming Crypto Deal Targets 6-Month Licensing Fast Track
Bitcoin.com Published 01.10.2026 21:50
-
Bitcoin Whale That Sat Through Every Crash Since 2020 Just Moved $377M
Decrypt Published 13.10.2026 19:38